The British Medical Journal hosts a point-counterpoint debate, with Peter Gøtzsche and Richard Smith arguing that the reasons for the boycott of tobacco-industry research – corruption and commercial motivations – are even stronger for pharmaceutical-funded research. Trish Groves, head of research for the BMJ, argues that the industry is increasing its integrity.
I feel some sympathy for Trish Groves. She chose (or was chosen) to defend an untenable position. Still…
Summary of Debate
Peter Gøtzsche and Richard Smith: the reasons for the boycott of tobacco-industry research – corruption and commercial motivations – are even stronger for pharmaceutical-funded research, and here’s why…
Trish Groves: No they’re not. Maybe you are. Maybe they are, but they’re getting better and we can help them lie less by publishing their lies. Here’s some other info that does not address any of the points you two made…
Oh, and
Really?
Report comment
Bwa-ha-ha-ha-ha-ha-ha…………………the drug companies are increasing their integrity! Yeah, and I have a plot of swampland in Florida to sell to Trish too!
Report comment